Maxcyte (MXCT)CFO bought ~$65K

~$65K

Approx. value · 50K sh @ $1.29

162K

Holds after · shares reported

Traded

Aug 13, 2025

Filed

Aug 13, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 25, 2025InsiderDirector sold ~$22K of MXCT shares in the open market
2. Aug 13, 2025 · this disclosureInsiderCFO purchased ~$65K of MXCT shares in the open market

What came next

1. Aug 13, 2025Insider · 4 peopleInsiders: 4 purchases (~$416K)
2. Sep 22, 2025Company filing · Form 8-K · Restructuring, Reg FDAnnounced job cuts, closures or a restructuring, and shared information with investors“On September 22, 2025, the Board of Directors of MaxCyte, Inc. approved a workforce reduction plan (the “Plan”) as part of the Company’s ongoing efforts to streamline operations, improve its cost structure, and align resources with strategic priorities.”
3. Nov 5, 2025Company filing · Form 8-K · ResultsReported its results
4. Nov 12, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Maxcyte

For Maxcyte, OQRO holds 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MXCT page.

Other recent filings by Douglas J Swirsky, CHIEF FINANCIAL OFFICER

• SEC Form 4 at Maxcyte (MXCT)Mar 20, 2025

The full history of Douglas J Swirsky, CHIEF FINANCIAL OFFICER is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Maxcyte

• USAspending.gov award recordAug 31, 2026
• USAspending.gov award recordMar 25, 2026
• SEC Form 4Aug 27, 2025
• SEC Form 4Aug 13, 2025
• SEC Form 4Aug 13, 2025
• SEC Form 4Aug 13, 2025

Everything OQRO holds on this company is on its MXCT page.